Amgen · 11 hours ago
Principal Scientist - Inflammation Biomarkers
United States
Full-time
Remote
Senior Level, Lead/Staff
$164K/yr - $196K/yr
4+ years expAmgen is a leading biotech company focused on serving patients with serious illnesses. The Principal Scientist - Inflammation Biomarkers will drive scientific and technical plans in collaboration with the Precision Medicine function and cross-functional stakeholders to innovate clinical biomarker strategies for inflammatory diseases.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Preparing clinical biomarker strategies, leading biomarker development, implementation, and execution for one or more programs
Responsible for biomarker elements in clinical protocols, biomarker analysis plans, regulatory submissions, investigator meetings, advisory boards and publications
Build productive relationships with team members and functional groups for integrating an aligned and prioritized clinical biomarker evidence plan that addresses clinical objectives and translational research
Partner with cross-functional stakeholders including to drive biomarker innovation at product level
Establish and implement biomarker studies and collaborations with academic laboratories/KOLs
Interpret and communicate key clinical biomarker findings to cross-functional teams including Precision Medicine teams and leadership
Responsible for robust clinical biomarker plans to deliver patient stratification/selection, pharmacodynamics, mechanism of action and resistance evidence from clinical trial samples
Qualification
Required
Doctorate degree in a bioscience or medical discipline and 2 years of industry experience
Master's degree in a bioscience or medical discipline and 4 years of industry experience
Bachelor's degree in a bioscience or medical discipline and 6 years of industry experience
Associate's degree in a bioscience or medical discipline and 10 years of industry experience
High school diploma / GED and 12 years of directly related industry experience
Preferred
PhD with 3 or more years pharmaceutical industry experience, developing biomarker strategies in a clinical development setting and/or in preclinical biomarker discovery/validation
Knowledge and translational biomarker experience in inflammation is highly desirable
Strong background in immunology, cell biology and genomics
Clinical development experience working with cross-functional teams conducting clinical trials
Experience in developing program-based strategies for pharmacodynamic, predictive, and exploratory biomarkers
Experience implementing a broad array of biomarker platforms and technologies to support clinical-stage programs
Demonstrated ability to establish and implement biomarker studies and collaborations with academic laboratories/KOLs
Experience in assay development and qualification and analysis of clinical samples
Experience managing biomarker assay outsourcing processes with external vendors and CROs
Poise and professionalism with strong communication and influencing skills in a dynamic environment
Benefits
A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models where possible.
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
pharmaphorum
2026-01-14
2026-01-13
Company data provided by crunchbase